US Stock MarketDetailed Quotes

MBRX Moleculin Biotech

Watchlist
  • 2.1800
  • +0.9100+71.65%
Close Feb 14 16:00 ET
  • 1.9700
  • -0.2100-9.63%
Post 20:01 ET
9.06MMarket Cap-0.18P/E (TTM)

About Moleculin Biotech Company

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.

Company Profile

SymbolMBRX
Company NameMoleculin Biotech
Listing DateJun 2, 2016
Issue Price6.00
Founded2015
CEOMr. Walter V. Klemp
MarketNASDAQ
Employees18
Fiscal Year Ends12-31
Address5300 Memorial Drive,Suite 950
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77007
Phone1-713-300-5160
Websitehttp://www.moleculin.com

Company Executives

  • Name
  • Position
  • Salary
  • Walter V. Klemp
  • Chairman of the Board, President and Chief Executive Officer
  • 1.41M
  • Jonathan P. Foster
  • Chief Financial Officer, Executive Vice President and Principal Accounting Officer
  • 840.64K
  • Dr. Donald H. Picker, PhD
  • Chief Scientific Officer
  • 599.11K
  • Robert E. George
  • Independent Director
  • 74.90K
  • Michael D. Cannon
  • Independent Director
  • 68.52K
  • John M. Climaco, Esq.
  • Lead Independent Director
  • 81.05K
  • Elizabeth A. Cermak
  • Independent Director
  • 63.52K
  • Dr. Joy Yan, M.D.,PhD
  • Independent Director
  • 47.15K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!